What Are GLP-1 Medications?

GLP-1 medications are prescription drugs that mimic or enhance the effects of a naturally occurring hormone called glucagon-like peptide-1, or GLP-1. This hormone helps regulate blood sugar, digestion, appetite, and feelings of fullness.

GLP-1 medications were originally developed primarily for the treatment of type 2 diabetes. Certain medications in this class are now also approved for chronic weight management, and they have become an important option in modern medical weight loss.

Medications such as semaglutide and liraglutide are true GLP-1 receptor agonists. Tirzepatide, another medication commonly discussed alongside GLP-1 drugs, works on both GLP-1 and GIP receptors and is technically considered a dual GIP/GLP-1 receptor agonist.

What Does GLP-1 Mean?

GLP-1 stands for glucagon-like peptide-1.

Your intestines naturally release GLP-1 after you eat. The hormone communicates with several parts of the body involved in metabolism and appetite.

Among its effects, GLP-1 can:

• Help the pancreas release insulin when blood sugar is elevated

• Reduce glucagon secretion

• Slow the rate at which food leaves the stomach

• Increase feelings of fullness after eating

• Reduce hunger and food intake

• Influence appetite-regulating centers in the brain

GLP-1 medications activate the same receptors but are designed to remain active much longer than the GLP-1 hormone your body naturally produces.

What Are Examples of GLP-1 Medications?

Several GLP-1 receptor agonists are currently used in medical care.

Some of the medications patients may recognize include:

Semaglutide

Semaglutide is the active ingredient in medications including Wegovy and Ozempic. Wegovy is approved for chronic weight management in appropriate patients, while Ozempic is primarily used for type 2 diabetes and certain related indications.

Liraglutide

Liraglutide is the active ingredient in Saxenda and Victoza. Saxenda has been approved for chronic weight management, while Victoza is used primarily in diabetes treatment.

Tirzepatide

Tirzepatide is the active ingredient in Zepbound and Mounjaro. Tirzepatide is not technically a GLP-1-only medication. It activates both GIP and GLP-1 receptors.

Zepbound is approved for chronic weight management in qualifying adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.

There are also other GLP-1 medications used primarily for diabetes.

Not every GLP-1 medication is FDA-approved specifically for weight loss, which is why the medication, formulation, indication, and individual patient all matter when treatment is being selected.

How Do GLP-1 Medications Help With Weight Loss?

GLP-1 medications can affect several biological processes involved in appetite and body weight.

For many patients, the most noticeable effect is reduced hunger. Patients may feel satisfied with smaller portions, stay full longer after meals, experience fewer food cravings, or find it easier to stop eating when they are satisfied.

This is different from simply trying to suppress hunger through willpower.

Body weight is influenced by complex interactions among hormones, the brain, metabolism, genetics, medications, sleep, nutrition, activity level, and the environment. GLP-1 medications act on some of the physiological pathways involved in regulating appetite and food intake.

They are therefore typically most useful when incorporated into a comprehensive treatment strategy rather than viewed as a replacement for nutrition, physical activity, sleep, resistance training, and other healthy behaviors.

You can learn more about these foundations in our Healthy Living & Nutrition Resource Center.

Are GLP-1 Medications Only for Weight Loss?

No.

GLP-1 receptor agonists were initially developed as medications for type 2 diabetes, and several continue to be widely used for blood sugar management.

Depending on the specific drug and formulation, GLP-1 medications may also have FDA-approved indications related to chronic weight management and cardiovascular risk reduction. Tirzepatide has additional approved uses that include chronic weight management and treatment of moderate-to-severe obstructive sleep apnea in adults with obesity.

The specific brand matters because two medications containing the same active ingredient may have different FDA-approved indications.

Is Ozempic the Same as Wegovy?

Not exactly.

Ozempic and Wegovy both contain semaglutide, but they are marketed and FDA-approved for different primary indications and may use different dosing strategies.

For patients interested specifically in treating overweight or obesity, physicians generally consider medications and formulations approved for chronic weight management when appropriate.

This distinction is one reason it is useful to discuss medication selection with a clinician rather than choosing treatment based solely on a medication's name or popularity.

Is Tirzepatide a GLP-1 Medication?

Technically, tirzepatide is a dual GIP and GLP-1 receptor agonist rather than a GLP-1 receptor agonist alone.

It activates:

• Glucose-dependent insulinotropic polypeptide, or GIP, receptors

• Glucagon-like peptide-1, or GLP-1, receptors

Because tirzepatide shares GLP-1 activity and is used for many of the same clinical purposes, patients and even general discussions about weight-loss medications frequently group it together with GLP-1 drugs.

From a medical standpoint, however, the distinction is worth understanding.

Are GLP-1 Medications Insulin?

No.

GLP-1 medications are not insulin.

Instead, they influence the body's own metabolic signaling pathways. Among other actions, GLP-1 receptor activation can encourage the pancreas to release insulin when glucose levels are elevated.

That glucose-dependent action is one of the reasons these medications were originally developed for the treatment of type 2 diabetes.

How Are GLP-1 Medications Taken?

Many GLP-1 medications are given as injections under the skin.

Depending on the medication, dosing may be:

• Once daily

• Once weekly

There are also oral formulations of certain GLP-1 medications.

For weight-management medications, physicians commonly start treatment at a relatively low dose and gradually increase the dose over time. Gradual dose escalation can help the body adjust to treatment and may improve gastrointestinal tolerability.

The exact schedule depends on the medication being prescribed.

What Are the Common Side Effects of GLP-1 Medications?

Because GLP-1 medications affect the gastrointestinal system, many of their most common side effects involve digestion.

Possible side effects include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Indigestion

• Feeling unusually full

Symptoms are often more noticeable when treatment begins or after the dose is increased.

GLP-1 and related medications can also have more serious potential adverse effects. Depending on the medication, warnings may include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, allergic reactions, and hypoglycemia when combined with certain diabetes medications.

This is one reason medical supervision and appropriate follow-up are important during treatment.

Who Should Not Take a GLP-1 Medication?

GLP-1 medications are not appropriate for everyone.

A physician should review your medical history, current medications, previous treatment, weight history, gastrointestinal health, diabetes history, and other relevant factors before prescribing treatment.

For example, commonly used medications such as semaglutide and tirzepatide carry boxed warnings related to thyroid C-cell tumors observed in animal studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Whether the animal findings translate into a human risk has not been established.

Pregnancy, certain gastrointestinal conditions, previous medication reactions, and other medical circumstances may also affect whether treatment is appropriate.

Eligibility should therefore be determined individually.

Do You Have to Have Diabetes to Take a GLP-1 Medication for Weight Loss?

No.

Certain GLP-1 medications are specifically approved for chronic weight management in people who do not have diabetes.

Whether someone qualifies depends on factors such as body mass index, weight-related medical conditions, age, medical history, previous treatment, and the particular medication being considered.

A medical evaluation can help determine whether medication is appropriate and whether another approach may be more suitable.

Are GLP-1 Medications a Replacement for Diet and Exercise?

No.

GLP-1 medications can make weight management significantly more achievable for some patients, but medication is only one component of treatment.

Prescribing information for medications used for chronic weight management generally recommends their use together with appropriate nutritional changes and increased physical activity.

A comprehensive medical weight loss plan may also address:

• Protein intake and overall nutrition

• Resistance training and preservation of muscle mass

• Cardiovascular exercise

• Sleep

• Stress

• Alcohol intake

• Medications that may contribute to weight gain

• Hormonal or metabolic conditions

• Laboratory abnormalities

• Long-term weight maintenance

This broader approach is one reason medically supervised treatment can be different from simply obtaining a prescription.

Do GLP-1 Medications Have to Be Taken Forever?

Not necessarily, but obesity and excess weight can behave like chronic medical conditions, and stopping treatment can allow appetite-regulating mechanisms to re-emerge.

Some patients may use medication for a limited period, while others may benefit from longer-term therapy.

The appropriate duration depends on factors such as:

• Treatment response

• Side effects

• Health goals

• Medical conditions

• Cost and medication access

• Ability to maintain weight after treatment

• Patient preference

Stopping medication should ideally be part of a long-term weight-management plan rather than an isolated decision.

How Quickly Do GLP-1 Medications Start Working?

Some patients notice appetite changes relatively early in treatment, while meaningful changes in body weight generally occur over a longer period.

Treatment is usually started at a lower dose and increased gradually rather than beginning immediately at the full maintenance dose.

Individual responses vary considerably. The goal should generally be safe, sustainable improvement in health and body composition, not simply losing weight as quickly as possible.

How Much Weight Can You Lose With a GLP-1 Medication?

There is no single amount that applies to everyone.

Weight loss can vary depending on:

• Which medication is used

• Dose

• Duration of treatment

• Starting weight

• Nutrition

• Physical activity

• Sleep

• Medical conditions

• Other medications

• Individual biology

• Ability to tolerate treatment

Some medications have produced substantial average weight reductions in clinical trials, but an individual patient's results may be higher or lower.

When evaluating treatment success, it can also be helpful to consider changes in waist circumference, metabolic health, blood pressure, blood sugar, physical function, and body composition rather than focusing exclusively on the number on the scale.

What Happens Before Starting a GLP-1 Medication?

Before treatment, a clinician may review:

• Your weight and weight history

• Current medications and supplements

• Medical conditions

• Previous weight-loss attempts

• Family medical history

• Blood pressure

• Blood sugar and metabolic health

• Relevant laboratory testing

• Nutrition and exercise habits

• Contraindications or medication interactions

• Your goals and expectations

Additional evaluation may be appropriate depending on the individual.

At Ask Dr. Hu, weight management is approached as part of an individual's overall health rather than as an isolated number on the scale. Patients who want to explore treatment can learn more about our GLP-1 Medical Weight Loss program or our broader Preventive Care & Health Optimization services.

So, What Are GLP-1 Medications?

GLP-1 medications are prescription drugs that activate receptors involved in blood sugar regulation, digestion, appetite, and fullness.

Medications such as semaglutide and liraglutide are GLP-1 receptor agonists, while tirzepatide combines GLP-1 activity with activity at the GIP receptor.

For appropriately selected patients, these medications can be useful tools for the treatment of obesity, overweight, type 2 diabetes, and certain related health conditions. They are most effective when medication selection, dosing, nutrition, physical activity, and long-term health goals are considered together.

If you are considering medication-assisted weight loss, learn more about GLP-1 Medical Weight Loss at Ask Dr. Hu.

Medical Review & Evidence

This article is intended to provide general patient education and is based on current information from authoritative medical and regulatory sources, including the U.S. Food and Drug Administration and the National Institute of Diabetes and Digestive and Kidney Diseases.

The FDA distinguishes traditional GLP-1 receptor agonists such as semaglutide and liraglutide from tirzepatide, which activates both GIP and GLP-1 receptors. FDA-approved indications, contraindications, formulations, and safety information can change over time, so medication decisions should be based on current prescribing information and individualized medical evaluation.

Medical Disclaimer: This information is for educational purposes and is not a substitute for individualized medical advice, diagnosis, or treatment. Prescription weight-loss medications should be used under the supervision of a qualified healthcare professional.

About the Author

YiQiu Hu, NMD is an Arizona-licensed naturopathic physician providing concierge medicine, preventive care, medical weight management, and individualized healthcare through Ask Dr. Hu. His approach emphasizes efficient access to medical care, thoughtful evaluation of the factors affecting each patient's health, and personalized treatment rather than a one-size-fits-all approach.

Explore additional physician-reviewed information in the Medical Weight Loss Resource Center.